lifestyle.californiaconsumerbanking.com

Author: FibroBiologics, Inc.

Breaking the Silence on Women’s Urologic Health

May 3, 2026
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology

May 1, 2026
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers

April 30, 2026
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis

April 29, 2026
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update

April 28, 2026
FibroBiologics Granted Extension by Nasdaq to Regain Compliance

April 28, 2026
Testicular Cancer Awareness Month Urges Men: Don’t Drop the Ball—Check Yours

April 1, 2026
FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University

March 9, 2026
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia

March 9, 2026